Table 2 Post-resuscitation care and outcomes
|  | Total (n = 111) | Survivors (n = 21) | Non-survivors (n = 90) | p value |
|---|---|---|---|---|
Initial laboratory data on admission to ED | ||||
 Serum hemoglobin, g/dL | 13.1 ± 2.6 | 15.2 ± 2.2 | 12.6 ± 2.4 | <0.001 |
 Platelets (103/µL) | 181.6 ± 85.5 | 188.6 ± 91.3 | 180.1 ± 84.6 | 0.690 |
 Serum lactatea, mmol/L | 12.4 ± 5.3 | 12.6 ± 4.7 | 12.4 ± 5.4 | 0.870 |
 Arterial pHb | 7.04 ± 0.20 | 7.08 ± 0.23 | 7.03 ± 0.20 | 0.309 |
 Serum bicarbonateb, mmol/L | 16.1 ± 6.1 | 14.3 ± 5.2 | 16.5 ± 6.2 | 0.146 |
 Base excessb, mmol/L | −14.6 ± 6.9 | −15.3 ± 7.0 | −14.4 ± 7.0 | 0.636 |
 Blood urea nitrogen, mg/dL | 19.6 ± 19.1 | 16.9 ± 6.6 | 20.2 ± 20.9 | 0.493 |
 Serum creatinine, mg/dL | 1.6 ± 2.0 | 1.3 ± 0.3 | 1.7 ± 2.2 | 0.495 |
 AST (IU/L) | 211 ± 551 | 208 ± 221 | 211 ± 603 | 0.982 |
 ALT (IU/L) | 168 ± 509 | 187 ± 224 | 163 ± 555 | 0.847 |
 Total bilirubin, mg/dL | 0.6 ± 0.5 | 0.6 ± 0.3 | 0.6 ± 0.5 | 0.760 |
 aPTT (sec) | 58.5 ± 45.0 | 52.1 ± 45.5 | 60.0 ± 45.0 | 0.484 |
 PT (INR) | 1.63 ± 1.99 | 1.25 ± 0.46 | 1.72 ± 2.19 | 0.340 |
SAPS II scoreb | 92 ± 7 | 88 ± 6 | 93 ± 6 | 0.004 |
MAP ≥ 60 mmHg, after ECPR | 62 (55.9) | 19 (90.5) | 43 (47.8) | <.001 |
Subsequent intervention after ECPR, n (%) | Â | Â | Â | Â |
 Coronary angiography | 89 (80.1) | 19 (90.5) | 70 (77.8) | 0.238 |
 Percutaneous coronary intervention | 59 (53.2) | 13 (61.9) | 46 (51.1) | 0.372 |
 Therapeutic hypothermia, n (%) | 31 (27.9) | 9 (42.9) | 22 (24.4) | 0.09 |
24-h survival, n (%) | 63 (56.8) | 21 (100) | 42 (46.7) | 0.002 |
Time from arrest to ECPR, min | 61 (42–88) | 56 (34–66) | 67(44–91) | 0.042 |
ECLS duration, h | 28 (6–58) | 75 (42–124) | 19 (4–48) | <.001 |
Hospital length of stay, days | 1 (0–6) | 30 (15–54) | 0 (0–2) | <.001 |
Cerebral performance category | Â | Â | Â | <.001 |
 1 or 2 | 17 (15.3) | 17 (81.0) | 0 |  |
 3 or 4 | 5 (4.5) | 4 (19.0) | 1 (1.1) |  |
 5 (organ donation) | 1 (0.9) | 0 | 1 (1.1) |  |